Table of contents

ORIGINAL ARTICLE

• Treatment of incidental adnexal masses at cesarean section: a retrospective study (1 February, 2007)

  M. Dede, M. C. Yenen, A. Yilmaz, U. Goktolga, İ. Baser
• Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004 (1 February, 2007)

  H. F. Wong, J. J.H. Low, Y. Chua, I. Busmanis, E. H. Tay, T. H. Ho
• Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer (1 February, 2007)

  M. Friedlander, M. Buck, D. Wyld, M. Findlay, B. Fitzharris, P. De Souza, T. Davies, G. Kalimi, S. Allan, D. Perez, P. Harnett
• Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study (1 February, 2007)

  P. Harnett, M. Buck, P. Beale, A. Goldrick, S. Allan, B. Fitzharris, P. De Souza, M. Links, G. Kalimi, T. Davies, R. Stuart-Harris
• A phase II clinical trial of topotecan and carboplatin in patients with newly diagnosed advanced epithelial ovarian cancer (1 February, 2007)

  F. Vecchione, R. Fruscio, T. Dell'Anna, A. Garbi, R. Garcia Parra, S. Corso, A. A. Lissoni
• Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: a California Cancer Consortium Trial (1 February, 2007)

  R. J. Morgan, T. W. Synold, D. Gandara, F. Muggia, S. Scudder, E. Reed, K. Margolin, J. Raschko, L. Leong, S. Shibata, M. Tetef, S. Vasilev, K. Mcgonigle, J. Longmate, Y. Yen, W. Chow, G. Somlo, M. Carroll, J. H. Doroshow
• A phase I study evaluating the safety and pharmacokinetics of weekly paclitaxel and carboplatin in relapsed ovarian cancer (1 February, 2007)

  A. L. Leiser, F. C. Maluf, D. S. Chi, P. Sabbatini, M. L. Hensley, L. Schwartz, E. Venkatraman, D. Spriggs, C. Aghajanian
• Validation and reduction of FACT/GOG-Ntx subscale for platinum/paclitaxel-induced neurologic symptoms: a gynecologic oncology group study (1 February, 2007)

  H. Q. Huang, M. F. Brady, D. Cella, G. Fleming
• Discordance of clinical symptoms and electrophysiologic findings in taxane plus platinum-induced neuropathy (1 February, 2007)

  Y. Pan, M.-S. Kao
• Molecular characterization of sarcomatous change in a granulosa cell tumor (1 February, 2007)

  J McNEILAGE, M Alexiadis, B.J Susil, P Mamers, T Jobling, G Laslett, A Trajstman, P. J. Fuller
• Characterization of an intraperitoneal ovarian cancer xenograft model in nude rats using noninvasive microPET imaging (1 February, 2007)

  C. L. Zavaleta, W. T. Phillips, Y. C. Bradley, L. M. McMANUS, P. A. Jerabek, B. A. Goins
• Peroxisome proliferator–activated receptor-γ agonists cause growth arrest and apoptosis in human ovarian carcinoma cell lines (1 February, 2007)

  Y.-C. Yang, Y.-P. Tsao, T.-C. Ho, I.-P Choung
• Sperm protein 17 influences the tissue-specific malignancy of clear cell adenocarcinoma in human epithelial ovarian cancer (1 February, 2007)

  T. Nakazato, T. Kanuma, T. Tamura, L. S. Faried, H. Aoki, T. Minegishi
• Patterns of practice and outcomes in intermediate- and high-risk stage I and II endometrial cancer: a population-based study (1 February, 2007)

  J. S. Kwon, M. S. Carey, E. F. Cook, F. Qiu, L. Paszat
• Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis (1 February, 2007)

  V. M. Chia, P. A. Newcomb, A. Trentham-Dietz, J. M. Hampton
• Exploring the potential chemopreventative effect of aspirin and rofecoxib on hereditary nonpolyposis colorectal cancer–like endometrial cancer cells in vitro through mechanisms involving apoptosis, the cell cycle, and mismatch repair gene expression

  (1 February, 2007)

  N. J. Wood, N. A. Quinton, S. Burdall, E. Sheridan, S. R. Duffy
• Clinical efficacy of conservative laser therapy for early-stage cervical cancer (1 February, 2007)

  H. Yamaguchi, M. Ueda, M. Kanemura, S. Izuma, K. Nishiyama, Y. Tanaka, S. Noda
• Radiotherapy negates the effect of retroperitoneal nonclosure for prevention of lymphedema of the legs following pelvic lymphadenectomy for gynecological malignancies: an analysis from a questionnaire survey (1 February, 2007)

  T. Tanaka, N. Ohki, A. Kojima, Y. Maeno, Y. Miyahara, T. Sudo, S. Takekida, S. Yamaguchi, H. Sasaki, R. Nishimura
• The prognostic significance of leukocytosis in cervical cancer (1 February, 2007)

  A. Garcia-Arias, L. Cetina, M. Candelaria, E. Robles, A. Dueñas-González
• Sentinel lymph node identification in a primary ductal carcinoma arising in the vulva (1 February, 2007)

  J. M. Martinez-Palones, A. Perez-Benavente, B. Diaz-Feijoo, A. Gil-Moreno, I. Roca, A. García-Jimenez, I. Aguilar-Martinez, J. Xercavins
• Study on CXCR4/SDF-1α axis in lymph node metastasis of cervical squamous cell carcinoma (1 February, 2007)

  J.-P. Zhang, W.-G. Lu, F. Ye, H.-Z. Chen, C.-Y. Zhou, X. Xie
• Differentially expressed genes between high-risk human papillomavirus types in human cervical cancer cells (1 February, 2007)

  G. Vazquez-Ortiz, J. A. García, C. J. Ciudad, V. Noé, S. Peñuelas, R. LÓPEZ-ROMERO, P. Mendoza-Lorenzo, P. Piña-Sánchez, M. Salcedo
• Epidermal growth factor 61 A/G polymorphism and uterine cervical cancer (1 February, 2007)

  S. Kang, J. W. Kim, N.-H. Park, Y.-S. Song, S.-Y. Park, S.-B. Kang, H.-P. Lee
• Human papillomavirus genotyping using HPV DNA chip analysis in Korean women (1 February, 2007)

  H. S. Lee, K. M. Kim, S. M. Kim, Y. D. Choi, J. H. Nam, C. S. Park, H. S. Choi
• Notch1 induces cell cycle arrest and apoptosis in human cervical cancer cells: involvement of nuclear factor kappa B inhibition (1 February, 2007)

  J. Yao, L. Duan, M. Fan, J. Yuan, X. Wu
• Blocking Notch1 signaling by RNA interference can induce growth inhibition in HeLa cells (1 February, 2007)

  H. Yu, X. Zhao, S. Huang, L. Jian, G. Qian, S. Ge